Design and biological evaluation of novel, balanced dual PPARalpha/gamma agonists - Test2 - elhamkhani - TriplyDB

Design and biological evaluation of novel, balanced dual PPARalpha/gamma agonists

Design and biological evaluation of novel, balanced dual PPARalpha/gamma agonists

http://www.wikidata.org/entity/Q27654470

about

A newly identified CG301269 improves lipid and glucose metabolism without body weight gain through activation of peroxisome proliferator-activated receptor alpha and gamma.DOCK 6: Impact of new features and current docking performance.Safety of Anti-Diabetic Therapies on Bone.A medicinal chemist's guide to molecular interactions Aromatic rings in chemical and biological recognition: energetics and structures.Effect of oxime ether incorporation in acyl indole derivatives on PPAR subtype selectivity.Comparative molecular profiling of the PPARα/γ activator aleglitazar: PPAR selectivity, activity and interaction with cofactors.Molecular modelling study of the PPARγ receptor in relation to the mode of action/adverse outcome pathway framework for liver steatosis.SAR and Computer-Aided Drug Design Approaches in the Discovery of Peroxisome Proliferator-Activated ReceptorγActivators: A Perspective

P2860

Q34527082-1F5888F7-2246-47F8-95C6-17C172C47AD2 Q35748554-064B7F7B-F113-4FA1-A361-B7A8BD3A641C Q36716222-E0249989-E18B-4474-8211-BAF3D1D30C37 Q37719514-0311FC5E-E51C-499C-9E12-90340E5CEBF1 Q37871537-C0623DFF-A261-47C9-995F-300DA5F4BD49 Q38320967-1EEE5449-0688-40F8-8659-CAAA6061CB0B Q39367068-9CCF3869-758B-41DF-A9F6-AE2A80221B35 Q40709802-42A742E3-EFB8-40F4-8754-56A9C46E8F0A Q58919671-D0A3C955-1AFD-49B0-A985-D679790E39AC

P2860

Design and biological evaluation of novel, balanced dual PPARalpha/gamma agonists

http://www.wikidata.org/entity/Q27654470

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Design and biological evaluation of novel, balanced dual PPARalpha/gamma agonists

@ast

Design and biological evaluation of novel, balanced dual PPARalpha/gamma agonists

@en

Design and biological evaluation of novel, balanced dual PPARalpha/gamma agonists

@nl

type

label

Design and biological evaluation of novel, balanced dual PPARalpha/gamma agonists

@ast

Design and biological evaluation of novel, balanced dual PPARalpha/gamma agonists

@en

Design and biological evaluation of novel, balanced dual PPARalpha/gamma agonists

@nl

prefLabel

Design and biological evaluation of novel, balanced dual PPARalpha/gamma agonists

@ast

Design and biological evaluation of novel, balanced dual PPARalpha/gamma agonists

@en

Design and biological evaluation of novel, balanced dual PPARalpha/gamma agonists

@nl

P1433

Q27654470-A3D6CEDF-CB68-4637-8212-F5857FF70D4C

P1476

Q27654470-B2E5DFAD-58FE-4745-8EB8-85260E92F01F

P2093

Q27654470-03192FE4-CFEC-4206-B504-E205D4A1C786

Q27654470-05FDF3FC-7F9F-473B-B71C-73E993CAD9F7

Q27654470-20465B95-9374-4E66-96BD-7F0D787215B6

Q27654470-2C0DCDC5-9B3B-476B-9B0D-7E5AEAC4864F

Q27654470-3A34EE32-814E-4C46-A5B8-30B63071DB5F

Q27654470-71A1A456-F2DF-4FA5-AB82-20042204DC69

Q27654470-8742823F-436E-460A-9622-F8C412F0D019

Q27654470-976131AE-5D0C-4690-92DF-82CC6390B9F9

Q27654470-9C53F71B-F02F-404E-BCB2-49C276318B9F

Q27654470-A68B17F3-9ABF-4943-BC30-DC9007C1DCCF

P2860

Q27654470-5C0AAF34-DFA5-4E46-BA01-D60A0C5BA635

Q27654470-ACB54821-0995-400A-AEB1-DE24D43C00EE

Q27654470-BF7E491D-D589-4EAD-A1BC-D9D3C4A20316

P304

Q27654470-6A0E65E1-6D62-4AE8-8FA6-336EA67A5AA0

P31

Q27654470-82243F7E-AAE8-4280-9E84-53B7CA77CD20

P356

Q27654470-E58A7DD2-C318-444F-BECC-82265199161A

P433

Q27654470-450A4E37-4EAD-4520-A11A-37007DA0970A

P478

Q27654470-28C13734-5A88-49D0-8B22-14E8439D4509

P577

Q27654470-61462D4C-CE68-485B-9A99-02F86213C0AF

P5875

Q27654470-F75589BA-817D-44AC-B1C2-1811B49258C0

P698

Q27654470-6E10B644-E38D-4C15-985A-15B0ED7419E2

P356

P1433

P1476

Design and biological evaluation of novel, balanced dual PPARalpha/gamma agonists

@en

P2093

Agnes Bénardeau

http://www.w3.org/2001/XMLSchema#string

Alfred Binggeli

http://www.w3.org/2001/XMLSchema#string

Armin Ruf

http://www.w3.org/2001/XMLSchema#string

Bernd Kuhn

http://www.w3.org/2001/XMLSchema#string

Daniel Schlatter

http://www.w3.org/2001/XMLSchema#string

Denise Blum

http://www.w3.org/2001/XMLSchema#string

Hans Hilpert

http://www.w3.org/2001/XMLSchema#string

Hans Peter Märki

http://www.w3.org/2001/XMLSchema#string

Jörg Benz

http://www.w3.org/2001/XMLSchema#string

Kurt Püntener

http://www.w3.org/2001/XMLSchema#string

P2860

Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalpha

Roles of PPAR delta in lipid absorption and metabolism: a new target for the treatment of type 2 diabetes.

PPAR: a mediator of peroxisome proliferator action.

P304

951-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CMDC.200800425

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2009-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24238938

http://www.w3.org/2001/XMLSchema#string

P698

19326383

http://www.w3.org/2001/XMLSchema#string